The pathogenesis of acute myeloid leukemia is associated with the appearanc
e of oncogenic fusion proteins generated as a consequence of specific chrom
osome translocations. Of the two components of each fusion protein, one is
generally a transcription factor, whereas the other partner is mo re variab
le in function, but often involved in the control of cell survival and apop
tosis. As a consequence, AML-associated fusion proteins function as aberran
t transcriptional regulators that interfere with the process of myeloid dif
ferentiation, determine a stage-specific arrest of maturation and enhance c
ell survival in a cell-type specific manner. The abnormal regulation of tra
nscriptional networks occurs through common mechanisms that include recruit
ment of aberrant corepressor complexes, alterations in chromatin remodeling
, and disruption of specific subnuclear compartments. The identification an
d analysis of common and specific target genes regulated by AML fusion prot
eins will be of fundamental importance for the full understanding of acute
myeloid leukemogenesis and for the implementation of disease-specific drug
design.